Navigation Links
PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution
Date:6/21/2010

uld not be mixed with any other drugs in the Altera Nebulizer Handset. Altera Nebulizer Systems are consistent with the specifications of the customized eFlow Nebulizer System used exclusively in all Cayston clinical trials. Altera is a drug-specific nebulizer system and its Instructions for Use specify that it is only to be used with Cayston.  Altera is not an ultrasonic nebulizer and it is not a general purpose electronic aerosol generator nebulizer.  No medication other than Cayston should be used in the Altera Nebulizer System.

The Altera Nebulizer System uses eFlow Technology to enable aerosolization of medication via a vibrating, perforated membrane that has thousands of small holes to produce the aerosol mist.  The Altera Nebulizer System and eFlow Technology are proprietary to PARI Pharma. 

About Cystic Fibrosis (CF)

CF is a chronic, debilitating genetic disease.  A major characteristic of CF is production of abnormally thick, sticky mucus in the lungs, trapping bacteria and predisposing patients to lung infections, which continually damage their lungs.  Chronic respiratory tract infection with P. aeruginosa contributes to the decline in pulmonary function, which is often associated with morbidity and mortality among CF patients. Currently there is no known cure for CF, and the goal of CF therapy is to control symptoms and prevent further lung damage.

About PARI Pharma

PARI Pharma focuses on the development of aerosol delivery devices and comprehensive inhalation drug development to advance aerosol therapies where drug and device can be optimized together. Based on PARI's 100-year history working with aerosols, PARI Pharma develops treatments for pulmonary and nasal administration customized with advanced delivery platforms,
'/>"/>

SOURCE PARI Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
2. Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
3. Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
4. Pharmasset Reports Fiscal Year End 2009 Financial Results
5. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
6. Pharmasset to Present at Lazard Capital Markets Healthcare Conference
7. Sosei Assigns AD 923 Assets to Pharmasol
8. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
9. Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
10. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
11. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, announced today that ... quarter fiscal year 2015 on Thursday, May 7, ... that same day, Thursday, May 7, 2015, at ...
(Date:5/1/2015)... N.J., May 1, 2015 Cambrex Corporation (NYSE: ... 31, 2015. Highlights , Sales ... increased 27% excluding foreign currency impact, driven by Innovator products ... from $8.4 million in the first quarter of 2014. ... $0.04 in the first quarter last year and Adjusted Diluted ...
(Date:4/30/2015)... 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: ... a focus on Omega-3 therapies for cardiovascular disease ... and financial results for the fiscal year ended ... are in Canadian dollars unless otherwise stated. ... with the right strategic partners and additional capitalization ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... 25, 2011 Angelini Labopharm, LLC, today ... Company.  Formerly Senior Vice President, Sales and Marketing for ... subsidiary, Labopharm USA, Inc., Ms. Heino,s primary focus will ... the commercialization of OLEPTRO™, as well as to explore ...
... N.J., Jan. 25, 2011 Johnson & Johnson (NYSE: ... the fourth quarter of 2010, a decrease of 5.5% as ... 5.1% and the negative impact of currency was 0.4%. Domestic ... operational decline of 2.3% and a negative currency impact of ...
Cached Medicine Technology:Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 2Angelini Labopharm Confirms Appointment of Mary Anne Heino as President 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 2Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 3Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 4Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 5Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 6Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 7Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 8Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 9Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 10Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 11Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 12Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 13Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results 14
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 NuevaCare ... MnemeTherapy® at two upcoming area seminars. The first event ... PSA Annual Regional Stroke Conference to be held at ... offered on Wednesday, May 13 during the Dementia Conference ... , “These seminars offer an excellent opportunity to ...
(Date:5/3/2015)... 2015 HealthPostures, a pioneering ergonomics ... its appearance at the , May 5 - 7, ... will exhibit at the conference include its bestselling TaskMate ... solutions is the 6100 TaskMate Executive. Features of the ... adjustable keyboard tray, extended platform work surface and supply ...
(Date:5/2/2015)... BC (PRWEB) May 02, 2015 Vancouver fencing ... will now provide valuable advice to prospective clients related to ... are looking to install railings around their decks and patios. ... several questions that pop up once the person rolls up ... phases of installing a railing in finding a gate that ...
(Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... An elevated rate of increase in prostate specific antigen (PSA) ... prostate cancer, according to a new study published in the ... rate of PSA increase prior to treatment (PSA Velocity) is ... high risk of death from prostate cancer. ,According ...
... A ten-day long festival for gays began in the capital ... will showcase over 20 films on homosexuality directed by many ... and a photographic presentation. ,The aim of the ... country where Section 377 of the Indian Penal Code (IPC) ...
... has adopted yet another spiritual ploy to keep her out of ... report to Los Angeles' Century Regional Detention Center by June 5, ... Mary. ,In the past few days Paris has been ... DVD called Innocent. ,Some pals feel that Hilton, who ...
... chemotherapy errors identified in children reach patients, according to ... errors in children . Published in the July 1, ... American Cancer Society, the study concluded that the antimetabolite ... errors, and that errors in drug administration and errors ...
... UK have discovered mutations in the DNA of four ... breast cancer in women . ,The discovery ... at higher-than-average risk of breast cancer so that they ... - the age when routine breast screening now begins. ...
... participating in one of the largest ever Parkinson's disease ... creatine can slow the symptom progression of this ... the brain in which patients develop tremor, slowness of ... one million people in the U.S. Currently, there are ...
Cached Medicine News:Health News:Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer 2Health News:Gay Film Festival Begins in Delhi 2Health News:Most Pediatric Chemotherapy Mistakes Reach Patients 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3Health News:Emory Participates in Study to Slow Progression of Parkinson's Disease 2
... feature powerful, maintenance-free motors, and ... rotors for unparalleled application versatility. ... one: a high capacity general ... a high-speed centrifuge for separating ...
... Rotor has a standard 1.5ml rotor and 6 ... Easy operation (no switches to mess with). Simply ... the plastic tab to open. Starts and stops ... 2000 x g. Only five inches in diameter. ...
... Personal Micro Centrifuges MiniSpin and MiniSpin plus ... they are powerful enough so that each ... centrifuge for a wide range of molecular ... are available to meet your performance requirements. ...
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
Medicine Products: